Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 2, 2015, Pages F103-F113

  Bicer, Fuat ^a,b   Altuntas, Cengiz Z ^a   Izgi, Kenan ^a,b   Ozer, Ahmet ^a,c   Kavran, Michael ^a   Tuohy, Vincent K ^d   Daneshgari, Firouz ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CROMOGLYCATE DISODIUM; LIDOCAINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANITIDINE; UROPLAKIN 3; HISTAMINE RECEPTOR; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UPK 3A 65 84; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; UPK3A PROTEIN, MOUSE;

ADULT; ALLODYNIA; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CHEMOKINE RECEPTOR 2 GENE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTALGIA; CYSTITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG HYPERSENSITIVITY; EXPERIMENTAL AUTOIMMUNE CYSTITIS; EXPERIMENTAL AUTOIMMUNE DISEASE; EXPERIMENTAL INFLAMMATION; EXPERIMENTAL UROGENITAL DISEASE; FEMALE; GENE; GENE DELETION; HYPERALGESIA; IMMUNOGENICITY; MALE; MAST CELL; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINARY DYSFUNCTION; VISCERAL PAIN; ALLERGIC REACTION; AUTOIMMUNITY; BAGG ALBINO MOUSE; IMMUNIZATION; INTERSTITIAL CYSTITIS; MECHANICAL STIMULATION; TACTILE STIMULATION; ANIMAL; BLADDER; COMPLICATION; DISEASE MODEL; HISTAMINE RELEASE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CETIRIZINE; CHEMOKINE CCL2; CROMOLYN SODIUM; CYSTITIS, INTERSTITIAL; DISEASE MODELS, ANIMAL; FEMALE; HISTAMINE RELEASE; HYPERALGESIA; MALE; MAST CELLS; MICE, INBRED BALB C; MICE, KNOCKOUT; RANITIDINE; RECEPTORS, CCR2; URINARY BLADDER; UROPLAKIN III;

EID: 84920964417     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00202.2014     Document Type: Article

References (58)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100: 7947–7952, 2003.
2. Aldenborg F, Fall M, Enerback L. Proliferation and trans-epithelial migration of mucosal mast-cells in interstitial cystitis. Immunology 58: 411–416, 1986.
3. Altuntas CZ, Daneshgari F, Sakalar C, Goksoy E, Gulen MF, Kavran M, Qin J, Li X, Tuohy VK. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis. Eur Urol 61: 193–200, 2012.
4. Arms L, Girard BM, Malley SE, Vizzard MA. Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation. Am J Physiol Renal Physiol 305: F111–F122, 2013.
5. Baba T, Nakamoto Y, Mukaida N. Crucial contribution of thymic Sirp α+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner. J Immunol 183: 3053–3063, 2009.
6. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ. Prevalence of symptoms of bladder pain syndrome/ interstitial cystitis among adult females in the United States. J Urol 186: 540–544, 2011.
7. Bjorling DE, Wang ZY, Bushman W. Models of inflammation of the lower urinary tract. Neurourol Urodyn 30: 673–682, 2011.
8. Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 177: 450–456, 2007.
9. Boucher W, el-Mansoury M, Pang X, Sant GR, Theoharides TC. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 76: 94–100, 1995.
10. Christmas TJ, Rode J, Chapple CR, Milroy EJ, Turner-Warwick RT. Nerve fibre proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol 416: 447–451, 1990.
11. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol 173: 98–102, 2005.
12. Collington SJ, Hallgren J, Pease JE, Jones TG, Rollins BJ, Westwick J, Austen KF, Williams TJ, Gurish MF, Weller CL. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J Immunol 184: 6114–6123, 2010.
13. Conti P, Boucher W, Letourneau R, Feliciani C, Reale M, Barbacane RC, Vlagopoulos P, Bruneau G, Thibault J, Theoharides TC. Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. Immunology 86: 434–440, 1995.
14. Denson MA, Griebling TL, Cohen MB, Kreder KJ. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. J Urol 164: 1908–1911, 2000.
15. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313–326, 2009.
16. Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, Thumbikat P, Pope RM, Landis JR, Koch AE, Schaeffer AJ. Monocyte chemoattractant protein-1 and macrophage inflammatory protein- 1α as possible biomarkers for the chronic pelvic pain syndrome. J Urol 179: 1852–1861, 2008.
17. Done JD, Rudick CN, Quick ML, Schaeffer AJ, Thumbikat P. Role of mast cells in male chronic pelvic pain. J Urol 187: 1473–1482, 2012.
18. el-Mansoury M, Boucher W, Sant GR, Theoharides TC. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 152: 350–353, 1994.
19. Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol 137: 35–38, 1987.
20. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192: 899–905, 2000.
21. Gaupp S, Pitt D, Kuziel WA, Cannella B, Raine CS. Experimental autoimmune encephalomyelitis (EAE) in CCR2(_/_) mice: susceptibility in multiple strains. Am J Pathol 162: 139–150, 2003.
22. Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9: 315–330, 1995.
23. Hohenfellner M, Nunes L, Schmidt RA, Lampel A, Thuroff JW, Tanagho EA. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol 147: 587–591, 1992.
24. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193: 713–726, 2001.
25. Huang M, Pang XH, Karalis K, Theoharides TC. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice. Cardiovasc Res 59: 241–249, 2003.
26. Izgi K, Altuntas CZ, Bicer F, Ozer A, Sakalar C, Li X, Tuohy VK, Daneshgari F. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice. PLOS ONE 8: e72067, 2013.
27. Keles N, Yavuz Arican R, Coskun M, Elpek GO. Histamine induces the neuronal hypertrophy and increases the mast cell density in gastrointestinal tract. Exp Toxicol Pathol 64: 713–716, 2012.
28. Kinet JP. The high-affinity IgE receptor (Fc εRI): from physiology to pathology. Annu Rev Immunol 17: 931–972, 1999.
29. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94: 12053–12058, 1997.
30. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92: 335–342, 2001.
31. Leiby BE, Landis JR, Propert KJ, Tomaszewski JE. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J Urol 177: 142–148, 2007.
32. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 77: 41–54, 1996.
33. Lieberman P. Histamine, antihistamines, and the central nervous system. Allergy Asthma Proc 30: 482–486, 2009.
34. Link CL, Pulliam SJ, Hanno PM, Hall SA, Eggers PW, Kusek JW, McKinlay JB. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey. J Urol 180: 599–606, 2008.
35. -ΔΔCT method. Methods 25: 402–408, 2001.
36. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187: 601–608, 1998.
37. Lundeberg T, Liedberg H, Nordling L, Theodorsson E, Owzarski A, Ekman P. Interstitial cystitis: correlation with nerve fibres, mast cells and histamine. Br J Urol 71: 427–429, 1993.
38. Lv JW, Luo Y, Leng J, Xue W, Liu DM, Huang YR. Aberrant expression of monocyte chemoattractant protein-1 (MCP-1) in interstitial cystitis patients. Sci Res Essays 5: 663–667, 2010. 39a.National Center for Biotechnology Information. PubChem Compound Database. Compound Summary for: CID 27503. Cromolyn Sodium (online). http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid?27503&loc=ec_rcs [24 September 2014].
39. Oliveira SM, Drewes CC, Silva CR, Trevisan G, Boschen SL, Moreira CG, de Almeida Cabrini D, Da Cunha C, Ferreira J. Involvement of mast cells in a mouse model of postoperative pain. Eur J Pharmacol 672: 88–95, 2011.
40. Pang X, Marchand J, Sant GR, Kream RM, Theoharides TC. Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 75: 744–750, 1995.
41. Peeker R, Enerback L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol 163: 1009–1015, 2000.
42. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states– maybe it is all in their head. Best Pract Res Clin Rheumatol 25: 141–154, 2011.
43. Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol 303: R580–R589, 2012.
44. Rudick CN, Bryce PJ, Guichelaar LA, Berry RE, Klumpp DJ. Mast cell-derived histamine mediates cystitis pain. PLOS ONE 3: e2096, 2008.
45. Rudick CN, Chen MC, Mongiu AK, Klumpp DJ. Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol 293: R1191–R1198, 2007.
46. Rudick CN, Schaeffer AJ, Klumpp DJ. Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol 9: 16, 2009.
47. Rudick CN, Schaeffer AJ, Thumbikat P. Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol 294: R1268–R1275, 2008.
48. Sant GR, Kempuraj D, Marchand JE, Theoharides TC. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69: 34–40, 2007.
49. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM; Interstitial Cystitis Clinical Trials Group. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170: 810–815, 2003.
50. Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol 31–74, 2009.
51. Sonoda KH, Yoshimura T, Egashira K, Charo IF, Ishibashi T. Neutrophil- dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice. Acta Ophthalmol 89: e180–188, 2011.
52. Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, McMahon SB. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13: 263–272, 2009.
53. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 57: 47–55, 2001.
54. Warren JW, Hanno PM. Symptoms of bladder pain syndrome. In: Bladder Pain Syndrome: a Guide for Clinicians, edited by Nordling J, Wyndaele JJ, van de Merwe JP, Bouchelouche P, Cervigni M, Fall M. New York: Springer Science+Business Media, 2013, p. 177–188.
55. Weller CL, Collington SJ, Williams T, Lamb JR. Mast cells in health and disease. Clin Sci 120: 473–484, 2011.
56. Wood JD. Visceral pain: spinal afferents, enteric mast cells, enteric nervous system and stress. Curr Pharm Des 17: 1573–1575, 2011.
57. Yoshimura N, Birder LA. Interstitial cystitis and related painful bladder syndromes: pathophysiology. In: Chronic Abdominal and Visceral Pain: Theory and Practice, edited by Pasricha PJ, Willis WD, Gebhart GF. New York: Informa Healthcare USA, 2006, p. 495–520.
58. Zhou J, Lee AW, Devidze N, Zhang Q, Kow LM, Pfaff DW. Histamineinduced excitatory responses in mouse ventromedial hypothalamic neurons: ionic mechanisms and estrogenic regulation. J Neurophysiol 98: 3143–3152, 2007.